Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Surprising

<< Previous

Bullboard Posts

Next >>

Comment by AlfonzoBallon Feb 19, 2021 11:08am

345 Views

Post# 32609441

RE:Surprising

Unfortunately we are at the mercy of the professional tree shaking at the moment that is all. The heavys know there is something good here and they are waging war for your shares. Hold strong if you are weak don't watch the share price. Nothing fundamental has changed. As Bio said they cannot release any substantial news untill the 24th when the bought deal closes. I would imagine Sernova has a pipeline of news coming after the 24th and through April. Lots of good things coming, Thyroid presentation early April , Meeting at the Med late April with peer Sigilon, and potential news about Global Pharm collabs. Should be a very exciting summer! Stay diamond my longs. Sending vibes.

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage